Peanut Allergy Treatment Market Forecasts to 2030 – Global Analysis By Treatment Type (Epinephrine, Antihistamines and Corticosteroids, Immunotherapy and Other Treatment Types), By Route Of Administration (Oral and Injectable), End User and By Geography
According to Stratistics MRC, the Global Peanut Allergy Treatment Market is accounted for $516.1 million in 2023 and is expected to reach $1169.8 million by 2030 growing at a CAGR of 12.4% during the forecast period. Peanut allergy treatment involves various strategies to manage and alleviate allergic reactions triggered by the consumption of peanuts. Approaches include allergen avoidance, emergency interventions with epinephrine, and allergen immunotherapy, aimed at desensitizing the immune system. These treatments aim to enhance patient safety, minimize allergic responses, and improve the overall quality of life for individuals with peanut allergies.
According to the ITC trade map, in 2021, Argentina exported 634,080 metric ton of peanuts, followed by India with 563,268 metric ton in second place.
Market Dynamics:
Driver:
Increasing prevalence of peanut allergy
With a rising number of individuals diagnosed with peanut allergies globally, there is a growing need for effective treatment options. This trend propels research and development efforts towards innovative therapies, including allergen immunotherapy, emergency interventions, and preventive measures. Moreover, the expanding patient pool fosters market growth as pharmaceutical companies and healthcare providers address the demand for advanced and accessible treatments to manage and mitigate the risks associated with peanut allergies.
Restraint:
High cost of treatment
Expenses associated with allergen immunotherapy, emergency interventions, and ongoing medical management contribute to the financial burden on patients and healthcare systems. Limited insurance coverage for certain treatments further exacerbates the cost barrier. This high financial threshold may deter some individuals from seeking or continuing treatment, impacting overall patient adherence and outcomes.
Opportunity:
Rising awareness and diagnosis rates
Increased awareness among healthcare professionals and the general public about peanut allergies leads to early detection and diagnosis. As awareness grows, more individuals seek medical attention, creating a larger patient pool for treatment options. This trend not only improves patient outcomes by enabling timely interventions but also drives the demand for effective peanut allergy treatments. Pharmaceutical companies and healthcare providers can capitalize on this opportunity by developing innovative treatments, fostering education initiatives, and contributing to a more comprehensive understanding of peanut allergies in both medical communities and the public.
Threat:
Limited access to specialists and treatment centers
Limited access to specialists and treatment centers poses a significant threat to the peanut allergy treatment market. Patients facing peanut allergies may encounter challenges in accessing specialized healthcare professionals and designated treatment facilities. This limitation can hinder timely diagnosis, personalized treatment plans, and the administration of allergen immunotherapy. The scarcity of trained specialists may contribute to gaps in patient care, impacting the effectiveness of interventions.
Covid-19 Impact:
The COVID-19 pandemic has impacted the peanut allergy treatment market by causing disruptions in healthcare services, including allergy diagnostics and treatments. Lockdowns, restrictions, and shifts in healthcare priorities led to delays in patient care, diagnosis, and treatment initiation. Additionally, the pandemic affected clinical trials and research activities, influencing the overall landscape of peanut allergy treatment. As the situation stabilizes, the market is gradually recovering, with an increased emphasis on patient safety and innovative treatment approaches.
The Immunotherapies segment is expected to be the largest during the forecast period
The immunotherapies segment is anticipated to be the largest in the peanut allergy treatment market during the forecast period. This dominance is attributed to the increasing adoption of allergen immunotherapy, including subcutaneous and sublingual approaches, aimed at desensitizing the immune system to peanuts. With a focus on addressing the root cause of peanut allergies and reducing allergic reactions, immunotherapies emerge as a preferred treatment option, contributing to the segment's substantial market share growth.
The injectable segment is expected to have the highest CAGR during the forecast period
The injectable segment is projected to experience lucrative growth in the peanut allergy treatment market during the forecast period. This growth is driven by the increasing preference for injectable forms of treatment, particularly the use of epinephrine auto-injectors for emergency management of severe allergic reactions. With a heightened focus on rapid and efficient intervention during allergic emergencies, the injectable segment is poised for substantial growth, offering a convenient and effective solution for patients and caregivers.
Region with largest share:
North America is poised to dominate the peanut allergy treatment market due to advanced healthcare infrastructure, heightened awareness of peanut allergies, and a proactive regulatory environment. The region's focus on innovative therapies, including immunotherapies, and a higher prevalence of peanut allergies contribute to its market leadership. Additionally, collaborations between healthcare organizations and research institutions further drive advancements in peanut allergy treatment, positioning North America as a key hub for developments and market dominance.
Region with highest CAGR:
The European region foresees rapid growth in the peanut allergy treatment market due to the increasing prevalence of peanut allergies, a strong emphasis on healthcare research, and advancements in treatment options. Rising awareness among healthcare professionals and patients, coupled with supportive regulatory frameworks, propels the adoption of innovative peanut allergy therapies. As research and development efforts intensify, Europe emerges as a significant contributor to advancements in peanut allergy treatment, driving substantial market growth in the forecasted period.
Key players in the market
Some of the key players in Peanut Allergy Treatment Market include Aimmune Therapeutics, ALK-Abelló A/S, Alladapt Immunotherapeutics, Inc, AnaptysBio, Inc., DBV Technologies SA, GlaxoSmithKline plc, HAL Allergy Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Prota Therapeutics, Regeneron Pharmaceuticals, Sanofi and Stallergenes Greer.
Key Developments:
In June 2023, Alladapt Immunotherapeutics, Inc. has unveiled topline results of Phase 1/2 Harmony study assessing effectiveness & safety of ADP101 for treating food allergies. Outcomes indicate dose-dependent, clinically significant responses, and a favorable safety profile in pediatric patients with single or multiple food allergies. These promising findings suggest ADP101's potential as a safe and effective treatment for children with common food allergies.
In May 2023, DBV Technologies has made an announcement that the results of its Phase 3 EPITOPE trial involving EPIT using Viaskin Peanut in children aged 1 to 3 years have been published in the New England Journal of Medicine. This publication underscores the potential of a new food allergy treatment option for this specific age group, offering hope for the management of food allergies in young children.
Treatment Types Covered:
• Epinephrine
• Antihistamines and Corticosteroids
• Immunotherapy
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Injectable
End Users Covered:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Peanut Allergy Treatment Market, By Treatment Type
- 5.1 Introduction
- 5.2 Epinephrine
- 5.3 Antihistamines and Corticosteroids
- 5.4 Immunotherapy
- 5.5 Other Treatment Types
- 6 Global Peanut Allergy Treatment Market, By Route Of Administration
- 6.1 Introduction
- 6.2 Oral
- 6.3 Injectable
- 7 Global Peanut Allergy Treatment Market, By End User
- 7.1 Introduction
- 7.2 Hospitals
- 7.3 Clinics
- 7.5 Ambulatory Surgical Centers
- 7.6 Homecare Settings
- 8 Global Peanut Allergy Treatment Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
- 9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
- 10 Company Profiling
- 10.1 Aimmune Therapeutics
- 10.2 ALK-Abelló A/S
- 10.3 Alladapt Immunotherapeutics, Inc
- 10.4 AnaptysBio, Inc.
- 10.5 DBV Technologies SA
- 10.6 GlaxoSmithKline plc
- 10.7 HAL Allergy Group
- 10.8 Merck & Co., Inc.
- 10.9 Mylan N.V.
- 10.10 Novartis AG
- 10.11 Pfizer Inc.
- 10.12 Prota Therapeutics
- 10.13 Regeneron Pharmaceuticals
- 10.14 Sanofi
- 10.15 Stallergenes Greer
- List of Tables
- Table 1 Global Peanut Allergy Treatment Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 3 Global Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 4 Global Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 5 Global Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 6 Global Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 7 Global Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 8 Global Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 9 Global Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 10 Global Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 11 Global Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 12 Global Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 13 Global Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 14 Global Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
- Table 15 North America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 16 North America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 17 North America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 18 North America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 19 North America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 20 North America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 21 North America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 22 North America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 23 North America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 24 North America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 25 North America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 26 North America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 27 North America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 28 North America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
- Table 29 Europe Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 30 Europe Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 31 Europe Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 32 Europe Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 33 Europe Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 34 Europe Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 35 Europe Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 36 Europe Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 37 Europe Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 38 Europe Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 39 Europe Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 40 Europe Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 41 Europe Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 42 Europe Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
- Table 43 Asia Pacific Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 44 Asia Pacific Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 45 Asia Pacific Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 46 Asia Pacific Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 47 Asia Pacific Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 48 Asia Pacific Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 49 Asia Pacific Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 50 Asia Pacific Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 51 Asia Pacific Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 52 Asia Pacific Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 53 Asia Pacific Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 54 Asia Pacific Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 55 Asia Pacific Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 56 Asia Pacific Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
- Table 57 South America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 58 South America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 59 South America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 60 South America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 61 South America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 62 South America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 63 South America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 64 South America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 65 South America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 66 South America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 67 South America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 68 South America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 69 South America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 70 South America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
- Table 71 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 72 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
- Table 73 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
- Table 74 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
- Table 75 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
- Table 76 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
- Table 77 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
- Table 78 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
- Table 79 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
- Table 80 Middle East & Africa Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 81 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 82 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
- Table 83 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 84 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook